|
About the Drugs Extension User Group category
|
|
0
|
92
|
February 21, 2025
|
|
Semantic tag for multicomponent clinical drugs
|
|
13
|
124
|
December 22, 2025
|
|
Dose form Intended sites vs. Routes of administration
|
|
19
|
184
|
December 11, 2025
|
|
DEUSG Meeting Notifications
|
|
4
|
51
|
December 8, 2025
|
|
Modelling inert tablets, diluents, and solvents
|
|
6
|
49
|
November 20, 2025
|
|
Strength Numerators in Gaseous Medicinal Products
|
|
3
|
53
|
November 18, 2025
|
|
Substances for "Extracts"
|
|
7
|
108
|
October 29, 2025
|
|
Unit of Measure - rationalisation of concepts
|
|
12
|
87
|
October 20, 2025
|
|
DEUSG Meeting Notification 20th October
|
|
0
|
17
|
October 19, 2025
|
|
|Administration of drug| versus |Drug therapy|
|
|
3
|
53
|
October 16, 2025
|
|
Increase range of has active ingredient to include microorganisms and natural products
|
|
1
|
41
|
October 16, 2025
|
|
DEUSG Meeting 9th October
|
|
0
|
24
|
October 7, 2025
|
|
DEUSG Virtual Meeting 25th September 2025
|
|
0
|
21
|
September 23, 2025
|
|
Naming Conventions for ‘Packaged Clinical Drugs’
|
|
2
|
31
|
September 16, 2025
|
|
Strength Representation in Drug Model
|
|
1
|
23
|
September 12, 2025
|
|
Hydration Subsumption
|
|
1
|
21
|
September 12, 2025
|
|
Less granular (generalized) clinical drug
|
|
1
|
42
|
September 12, 2025
|
|
Additional Attributes for National Drug Extensions
|
|
0
|
17
|
September 10, 2025
|
|
Next DEUSG meeting
|
|
0
|
21
|
September 10, 2025
|